In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given ...

More than 60% of patients with relapsed or refractory KMT2Ar acute leukemia responded to the menin inhibitor revumenib.

Researchers at Children's Hospital of Philadelphia (CHOP) revealed for the first time that children, adolescents and young ...

A new risk stratification system aims to improve decision making on which older patients with acute myeloid leukemia (AML) ...

Researchers sought to analyze deidentified sociodemographic and clinical data for children, adolescents, and young adults in the US who have cancer and COVID-19.

NeoGenomics' AML Express is an NGS assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia.

For umbilical cord blood transplant (UCBT), overall survival has improved over time, according to a study published in the ...

Mutations in the gene TET2 have been previously linked with cancer. Now scientists may have solved the persistent mystery of why this link exists, and that means a set of new targets for cancer ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, announced today the launch of AML Express, a next-generation sequencing (NGS) assay designed to provide rapid, ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

The annual prize is awarded to a Jewish humanitarian under age 50 whose work has significantly benefitted humankind.

The show is open to trucks, cars, bikes and tractors, at just $5 per vehicle. Entry is $5 per adult, and free for kids under ...